Skip to main content
Regulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUpcoming Events Regulatory Affairs NewsletterUpcoming Events Regulatory Affairs Newsletter Archive

How do AI regulations effect medical device development?

Understand the impact of AI and emerging regulations on medical device development Thursday, December 12, 2024 | 09:00 AM (CST) - 10:00 AM (CST) Artificial intelligence (AI) is poised to transform medical engineering, but regulatory frameworks significantly impact its deployment in the healthcare industry. Join our webinar on Dec. 12, 2024, to deepen your understanding of the impact of AI…
Ben Kemp
December 4, 2024
Regulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUpcoming Events Regulatory Affairs NewsletterUpcoming Events Regulatory Affairs Newsletter Archive

QARAD: What’s the latest in the field of In Vitro Diagnostics?

Be ready to tackle the challenges of clinical performance studies under the IVDR 5 December 2024 | 16:00 CET Are you in full preparation for a new IVD submission or looking to refine your current approach? Then our upcoming webinar ‘Mastering Clinical Performance Studies under IVDR’ will provide actionable guidance to help you succeed. Our IVD experts will delve into…
Ben Kemp
December 4, 2024
Membership NewsMembership News Archive

Responsible AI: Women and Healthcare Conference 2025

Members have until Monday 9th December 2024 to register for the Responsible AI: Women and Healthcare Conference taking place on Thursday 30th January 2025 at the Royal College of Obstetricians and Gynaecologists in London. Spaces are limited due to popularity. This event brings together healthcare leaders, innovators and experts from across the fields of artificial intelligence and women’s health to…
Ben Kemp
December 4, 2024
HighlightsHighlights ArchiveSustainability Programme Archive

BIVDA member Oxford Nanopore to create world-first ‘epigenetic map’

The Government has announced that BIVDA member Oxford Nanopore will use their breakthrough genetic sequencing tech to analyse 50,000 samples from UK Biobank, to create a world-first ‘epigenetic map’. This will help to get towards the root causes of diseases like cancer, dementia and heart disease, which could lead to breakthroughs in new diagnoses and treatments. This new resource for…
Ben Kemp
December 3, 2024
Membership NewsMembership News Archive

BIVDA submit NHS 10-year plan consultation response

BIVDA have submitted our response to the Government's NHS 10-year plan consultation. We highlighted how diagnostics are a key driver to achieving the NHS’s three shifts and to support the NHS as a health economic agency. With an ageing population and many economically inactive due to preventable long- term conditions, proactive diagnosis enables precision treatment and informed lifestyle change, enabling…
Ben Kemp
December 3, 2024